Alfresa Holdings logo

Alfresa Holdings

Asia, Tokyo, Japan, Tokyo

Description

Alfresa deals with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices.

Investor Profile

Alfresa Holdings has backed more than 3 startups, with 2 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Corporate Round rounds (top funding stages).
  • Majority of deals are located in Japan.
  • Strong thematic focus on Health Care, Medical, Biotechnology.
  • Led 2 rounds in the past year.

Stage Focus

  • Series B (33%)
  • Series C (33%)
  • Corporate Round (33%)

Country Focus

  • Japan (100%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Emergency Medicine
  • Medical Device
  • Oncology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alfresa Holdings frequently co-invest with?

Japan Lifeline
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Dai-ichi Life
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Co-Investments: 1
Sony Innovation Fund
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
MAKOTO Capital
Asia, Miyagi, Japan, Sendai
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
KSP
Asia, Kanagawa, Japan, Kawasaki
Co-Investments: 1

What are some of recent deals done by Alfresa Holdings?

HekaBio

Tokyo, Tokyo, Japan

HekaBio is an ecosystem for a healthcare development platform that provides therapeutic treatments in oncology and ophthalmology.

Health CareMedicalMedical DeviceOncologyPharmaceutical
Corporate RoundJun 16, 2025
Gexval

Fujisawa, Kanagawa, Japan

Gexval is a healthcare firm that help patients and families fighting against orphan and intractable diseases.

Emergency MedicineHealth CareMedical
Series CJan 16, 2025
Amount Raised: $1,930,872
Metcela

Kawasaki, Kanagawa, Japan

Metcela is a clinical-stage biotech startup providing patients with an alternative treatment option for heart disease.

BiotechnologyHealth CareMedical
Series BJan 4, 2021
Amount Raised: $12,700,000